164 related articles for article (PubMed ID: 26376635)
1. From Bone Marrow Necrosis to Gaucher Disease; A Long Way to Run.
Erdem N; Çizmecioğlu A; Aydoğdu İ
Turk J Haematol; 2015 Dec; 32(4):373-4. PubMed ID: 26376635
[No Abstract] [Full Text] [Related]
2. Positive heterophile antibody test and massive splenomegaly in an adolescent with previously unsuspected Gaucher disease.
Chou ST; Shah SS; Hodinka RL; Cohen AR
Pediatr Emerg Care; 2004 Mar; 20(3):181-184. PubMed ID: 15094578
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures.
Rim JH; Baik M; Yoon SO; Heo K; Song J
Ann Lab Med; 2016 Mar; 36(2):177-9. PubMed ID: 26709268
[No Abstract] [Full Text] [Related]
4. Pathologic quiz case. A 14-year-old boy with splenomegaly. Pathologic diagnosis: Gaucher disease.
Khan SB; Alkan S; Pooley R
Arch Pathol Lab Med; 2000 Aug; 124(8):1239-40. PubMed ID: 10923094
[No Abstract] [Full Text] [Related]
5. Enzyme Replacement Therapy in a Gaucher Family.
Erdem N; Buran T; Berber I; Aydogdu I
J Natl Med Assoc; 2018 Aug; 110(4):330-333. PubMed ID: 30126557
[TBL] [Abstract][Full Text] [Related]
6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2003. A nine-year-old girl with hepatosplenomegaly and pain in the thigh.
Larsen EC; Connolly SA; Rosenberg AE
N Engl J Med; 2003 Jun; 348(26):2669-77. PubMed ID: 12826642
[No Abstract] [Full Text] [Related]
7. Saccade testing in the diagnosis and treatment of type 3 Gaucher disease.
Pensiero S; Accardo A; Pittis MG; Ciana G; Bembi B; Perissutti P
Neurology; 2005 Dec; 65(11):1837. PubMed ID: 16344538
[No Abstract] [Full Text] [Related]
8. Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1.
Machaczka M; Klimkowska M
Ann Hematol; 2014 Oct; 93(10):1787-9. PubMed ID: 24577513
[No Abstract] [Full Text] [Related]
9. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
Kelman CG; Disler DG
J Comput Assist Tomogr; 2000; 24(1):173-5. PubMed ID: 10667678
[TBL] [Abstract][Full Text] [Related]
10. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
Kawahara S; Kato A; Oshimi K; Ida H
Rinsho Ketsueki; 2008 May; 49(5):335-9. PubMed ID: 18572811
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
[TBL] [Abstract][Full Text] [Related]
12. Case 20-2003: Gaucher's disease.
Beutler E
N Engl J Med; 2004 Jan; 350(4):416-7; discussion 416-7. PubMed ID: 14736939
[No Abstract] [Full Text] [Related]
13. [Gaucher disease--one of the possible causes of splenomegaly--case report].
Sokołowska B; Skomra D; Czartoryska B; Tomczak W; Tylki-Szymańska A; Repelewska M; Drop A; Gromek T
Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093
[TBL] [Abstract][Full Text] [Related]
14. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
[No Abstract] [Full Text] [Related]
15. [Hematological aspects of Gaucher disease].
Costello R; O'Callaghan T; Baccini V; Sébahoun G
Rev Med Interne; 2007 Oct; 28 Suppl 2():S176-9. PubMed ID: 18228684
[TBL] [Abstract][Full Text] [Related]
16. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
17. Gaucher's disease initially diagnosed as depression.
Clemons J; Jasser MZ; Noble G; Monahan BP
Am J Psychiatry; 1997 Feb; 154(2):290. PubMed ID: 9016289
[No Abstract] [Full Text] [Related]
18. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR.
Allison JW; James CA; Arnold GL; Stine KC; Becton DL; Bell JM
Pediatr Radiol; 1998 Apr; 28(4):237-40. PubMed ID: 9545478
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy.
Magnaldi S; Longo R; Ukmar M; Zanatta M; Bottega M; Sottocasa GL
Eur Radiol; 1997; 7(4):486-91. PubMed ID: 9204325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
